Introduction and Epidemiology

Necrotizing enterocolitis (NEC) is a devastating intestinal emergency primarily affecting preterm neonates.
More than 85% of cases occur in preterm (less than 32 weeks gestation) and very low birth weight (VLBW) babies.
The incidence ranges from 2% to 7% among VLBW infants, and the mortality ranges from 20% to 40%.
The mean age at onset is around 12 days, usually presenting at a postmenstrual age of 29 to 31 weeks.

Pathogenesis and Risk Factors

NEC is a multifactorial disease resulting from an interplay between gut immaturity, abnormal microbiome, and mucosal injury.

Factor Category	Specific Risk Factors
Immaturity	Extreme prematurity is the most significant risk factor. Decreased motility, increased epithelial permeability, and lack of secretory IgA predispose the gut to injury.
Nutritional	Formula milk feeding increases the risk, whereas exclusive mother's own milk (MOM) is protective. Higher osmolarity of feeds or medications may contribute to mucosal injury.
Microbiome	Decreased microbial diversity and overgrowth of pathogenic bacteria (dysbiosis) trigger the disease. Prolonged empirical antibiotic use disrupts the normal flora.
Hypoxic-Ischemic	Severe fetal growth restriction (FGR) with absent or reversed end-diastolic flow (AREDF) causes mesenteric ischemia. Perinatal asphyxia and polycythemia are associated with term NEC.
Medical Interventions	Blood transfusions for severe anemia (transfusion-associated NEC), use of H2 receptor antagonists, and umbilical arterial catheterization are associated with increased risk.
Inflammatory	Inappropriate innate immune responses involving platelet-activating factor (PAF), tumor necrosis factor-alpha, and toll-like receptor 4 lead to severe inflammation and necrosis.

Clinical Presentation

The clinical presentation can be fulminant and rapidly progressive, or insidious with signs of sepsis and feed intolerance.
Systemic signs include temperature instability, worsening apnea, respiratory distress, bradycardia, lethargy, poor perfusion, and shock.
Gastrointestinal signs typically dominate the clinical picture.
Early abdominal signs include feed intolerance, abdominal distension, and bilious or blood-stained gastric aspirates.
Established NEC is characterized by absent bowel sounds (ileus), abdominal wall erythema or induration, gross blood in stools, a persistent localized abdominal mass, and ascites.

Modified Bell's Staging

The severity of NEC is classified using the Modified Bell's staging system to guide prognosis and management.

Stage	Systemic Signs	Local Abdominal Signs	Radiological Signs
Stage 1 (Suspect)	Temperature instability, apnea, bradycardia.	Mild abdominal distension, large gastric residuals, occult (1A) or gross(1B) blood in stool.**	Normal bowel gas pattern or mild ileus.
Stage 2A (Mildly ill)	Same as Stage 1.	Prominent abdominal distension, absent bowel sounds, abdominal tenderness.	Ileus, pneumatosis intestinalis.
Stage 2B (Moderately ill)	Mild metabolic acidosis, thrombocytopenia.	Abdominal wall edema with palpable loops and tenderness.	Portal venous gas, with or without ascites.
Stage 3A (Advanced)	Hypotension, mixed acidosis, disseminated intravascular coagulation (DIC).	Worsening abdominal wall erythema, generalized peritonitis, marked tenderness.	Definite ascites, severe pneumatosis.
Stage 3B (Advanced)	Refractory shock, clinical deterioration.	Severe peritonitis.	Pneumoperitoneum (indicating bowel perforation).

Differential Diagnosis

Condition	Differentiating Features
Spontaneous Intestinal Perforation (SIP)	Occurs earlier (5-10 days of life), lacks mucosal necrosis or pneumatosis, associated with indomethacin or steroid use.
Feeding Intolerance	Mild gastric residuals without systemic toxicity. Differentiating early NEC requires cautious withholding of feeds and serial monitoring.
Late-Onset Sepsis	Systemic signs are identical, but localizing abdominal signs (erythema, pneumatosis) point toward NEC.
Surgical Catastrophes	Malrotation with volvulus presents with bilious vomiting and rapid shock, often requiring contrast imaging for distinction.
Cow's Milk Allergy	Presents with bloody stools and pneumatosis, but the neonate appears well and responds to milk protein elimination.

Investigations

Laboratory Tests

Complete blood count frequently demonstrates neutropenia and a shift to the left.
Thrombocytopenia is a prominent feature and an indicator of disease severity.
The classic metabolic triad in NEC consists of severe refractory hyponatremia, persistent metabolic acidosis, and thrombocytopenia.
Blood cultures are positive in up to 40% of cases, guiding antibiotic therapy.
Coagulation profiles should be monitored for DIC (elevated prothrombin time, decreased fibrinogen).

Radiological and Imaging Modalities

X-ray abdomen (anteroposterior and cross-table lateral views) is the primary imaging modality.
Early X-ray signs include loss of the normal polygonal bowel gas pattern, replaced by parallel lines (sausage pattern), or fixed bowel loops on serial films.
Pneumatosis intestinalis (intramural gas appearing as a train-track of tiny cysts) is the radiologic hallmark of NEC.
Portal venous gas appears as a branching tree pattern over the liver shadow.
Pneumoperitoneum indicates bowel perforation, presenting as the football sign, Rigler's sign (double wall sign), or air under the diaphragm.
Ultrasonography is increasingly utilized as it is radiation-free, sensitive for detecting portal venous gas, bowel wall thickening, absent peristalsis, and early ascites.

Management

Medical Management

Bowel rest is mandatory. Enteral feeding must be discontinued immediately, and gastric decompression initiated with a continuous orogastric tube.
Total parenteral nutrition (TPN) through central venous access is essential to meet caloric and protein needs during the fasting period (typically 7 to 14 days).
Fluid resuscitation and inotropic support are vital for maintaining systemic and splanchnic perfusion in the presence of shock.
Broad-spectrum antibiotics (covering Gram-negative, Gram-positive, and sometimes anaerobic organisms) should be initiated for 7 to 14 days, depending on the stage and culture reports.
Correct metabolic acidosis, hypoglycemia, and electrolyte imbalances aggressively.
Blood products (packed red blood cells, fresh frozen plasma, platelets) should be administered to correct anemia and coagulopathy.

Surgical Management

Early pediatric surgery consultation is essential.
Absolute indications for surgery include pneumoperitoneum or evidence of necrotic bowel (persistent fixed loop, refractory acidosis, abdominal wall erythema, and progressive shock).
Laparotomy with resection of the necrotic bowel segment and creation of a proximal enterostomy is the standard procedure.
Primary peritoneal drainage under local anesthesia may be used as a temporizing measure in extremely unstable ELBW neonates.
Re-anastomosis is usually performed electively after a period of adequate healing and growth.

Complications and Prognosis

Uncomplicated NEC has a favorable long-term prognosis, but Stage 3 NEC carries a mortality rate exceeding 50%.
Gastrointestinal complications include intestinal strictures (occurring in 25% to 35% of survivors), short bowel syndrome, enteric fistulas, and malabsorption.
Prolonged TPN dependence increases the risk of intestinal failure-associated liver disease (IFALD).
Survivors are at a significantly increased risk of long-term neurodevelopmental impairment and metabolic bone disease.

Prevention

Antenatal corticosteroids improve gastrointestinal maturity and reduce NEC risk.
Exclusive human milk feeding (MOM or pasteurized donor human milk) provides significant protection compared to preterm formula.
Standardized feeding regimens, including the early use of minimal enteral nutrition, ensure safe feed escalation and decrease the incidence of NEC.
Probiotics, such as Lactobacillus rhamnosus GG, have strong evidence supporting their role in normalizing gut flora and reducing NEC rates.
Antibiotic stewardship and restricting the use of H2 receptor antagonists are critical to preventing gut dysbiosis.